Date: June 22, 2022
Time: 10:00am (PDT), 1:00pm (EDT), 7:00pm (CEST)
Rabbits have a robust and unique immune system that enables the generated antibodies with superior specificity, affinity, and diversity. However, due to the long evolutionary distance between rabbit and human, the humanization has always been the bottleneck in rabbit mAb drug development. In addition, product quality and on-time delivery are also important to be considered. GenScript Antibody Department has successively introduced Beacon platform (by Berkeley Lights), the single B cell sorting method, and developed B cell cloning method for rabbit mAb discovery with high quality and short turnaround time. Based on this, this webinar will focus on the antibody development issues that drug developers are most concerned about. We will take the popular target 4-1BB as a case study to introduce GenScript's antibody development platforms, providing one-stop and rapid antibody development solutions in your antibody drug development.
- Discuss the advantages of rabbit monoclonal antibodies in antibody drug discovery projects.
- Learn the current status of rabbit monoclonal antibody humanization technology.
- GenScript provides fast and high-quality antibody drug discovery solutions for popular drug targets, e.g., 4-1BB.
Webinars will be available for unlimited on-demand viewing after live event.